The association of genetic variants in interleukin-1 genes with cognition: Findings from the cardiovascular health study

Experimental Gerontology

Volumn 46, Issue 12, 2011, Pages 1010-1019

  Benke, K S ^a,e   Carlson, M C ^a   Doan, B Q ^a   Walston, J D ^a   Xue, Q L ^a   Reiner, A P ^b,c   Fried, L P ^a,d   Arking, D E ^a   Chakravarti, A ^a   Fallin, M D ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

^d Columbia University Mailman School of Public Health ^*  (United States)

^e MOUNT SINAI HOSPITAL   (Canada)

Author keywords

Cognition; Genetic epidemiology; Inflammation; Interleukin 1; Longitudinal study

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 1A; INTERLEUKIN 1B; INTERLEUKIN 1RN; UNCLASSIFIED DRUG;

AFRICAN AMERICAN; AGED; ARTICLE; CARDIOVASCULAR SYSTEM; CAUCASIAN; COGNITION; CONTROLLED STUDY; EDUCATIONAL STATUS; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; IMMUNE RESPONSE GENE; INTERLEUKIN 1 GENE; INTERLEUKIN 1B GENE; INTERLEUKIN 1RN GENE; MALE; MENTAL PERFORMANCE; NEUROPATHOLOGY; PRIORITY JOURNAL; RACE DIFFERENCE; SENILE DEMENTIA; SINGLE NUCLEOTIDE POLYMORPHISM;

AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; COGNITION; COGNITION DISORDERS; DEMENTIA; EDUCATIONAL STATUS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOTYPE; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1ALPHA; INTERLEUKIN-1BETA; LINKAGE DISEQUILIBRIUM; LONGITUDINAL STUDIES; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; RISK FACTORS; UNITED STATES;

EID: 80855139971     PISSN: 05315565     EISSN: 18736815     Source Type: Journal    
DOI: 10.1016/j.exger.2011.09.005     Document Type: Article

References (58)

1. Akiyama H., Barger S., Barnum S., Bradt B., Bauer J., Cole G.M., Cooper N.R., Eikelenboom P., Emmerling M., Fiebich B.L., Finch C.E., Frautschy S., Griffin W.S., Hampel H., Hull M., Landreth G., Lue L., Mrak R., Mackenzie I.R., McGeer P.L., O'Banion M.K., Pachter J., Pasinetti G., Plata-Salaman C., Rogers J., Rydel R., Shen Y., Streit W., Strohmeyer R., Tooyoma I., Van Muiswinkel F.L., Veerhuis R., Walker D., Webster S., Wegrzyniak B., Wenk G., Wyss-Coray T. Inflammation and Alzheimer's disease. Neurobiol. aging 2000, 21:383-421.
2. Albert M.S. Cognitive and neurobiologic markers of early Alzheimer disease. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:13547-13551.
3. Albert M.S. Memory decline: the boundary between aging and age-related disease. Ann. Neurol. 2002, 51:282-284.
4. Arbelaez J.J., Ariyo A.A., Crum R.M., Fried L.P., Ford D.E. Depressive symptoms, inflammation, and ischemic stroke in older adults: a prospective analysis in the cardiovascular health study. J. Am. Geriatr. Soc. 2007, 55(11):1825-1830.
5. Barrett J.C., Fry B., Maller J., Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21:263-265. (Oxford, England).
6. Baune B.T., Ponath G., Rothermundt M., Riess O., Funke H., Berger K. Association between genetic variants of IL-1beta, IL-6 and TNF-alpha cytokines and cognitive performance in the elderly general population of the MEMO-study. Psychoneuroendocrinology 2008, 33:68-76.
7. Brennan R., Jorgensen L., Gordon S., Loades K., Hackett C., Russell J. The development of a PCR-based marker linked to resistance to the blackcurrant gall mite (Cecidophyopsis ribis Acari: Eriophyidae). TAG Theor. Appl. Genet. 2009, 118:205-211.
8. Cechetto D.F., Hachinski V., Whitehead S.N. Vascular risk factors and Alzheimer's disease. Expert. Rev. Neurother. 2008, 8:743-750.
9. de Bakker P.I., Yelensky R., Pe'er I., Gabriel S.B., Daly M.J., Altshuler D. Efficiency and power in genetic association studies. Nat. Genet. 2005, 37:1217-1223.
10. Déniz-Naranjo M.C., Muñoz-Fernandez C., Alemany-Rodríguez M.J., Pérez-Vieitez M.C., Aladro-Benito Y., Irurita-Latasa J., Sánchez-García F. Cytokine IL-1 beta but not IL-1 alpha promoter polymorphism is associated with Alzheimer disease in a population from the Canary Islands, Spain. Eur. J. Neurol. 2008, 15(10):1080-1084.
11. Elkins J.S., Longstreth W.T., Manolio T.A., Newman A.B., Bhadelia R.A., Johnston S.C. Education and the cognitive decline associated with MRI-defined brain infarct. Neurology 2006, 67:435-440.
12. Engelhart M.J., Geerlings M.I., Meijer J., Kiliaan A., Ruitenberg A., van Swieten J.C., Stijnen T., Hofman A., Witteman J.C., Breteler M.M. Inflammatory proteins in plasma and the risk of dementia: the rotterdam study. Arch. Neurol. 2004, 61:668-672.
13. Fried L.P., Borhani N.O., Enright P., Furberg C.D., Gardin J.M., Kronmal R.A., Kuller L.H., Manolio T.A., Mittelmark M.B., Newman A., et al. The Cardiovascular Health Study: design and rationale. Ann. Epidemiol. 1991, 1:263-276.
14. Giedraitis V., Kilander L., Degerman-Gunnarsson M., Sundelöf J., Axelsson T., Syvänen A.C., Lannfelt L., Glaser A. Genetic analysis of Alzheimer's disease in the Uppsala longitudinal study of adult men. Dement. Geriatr. Cogn. Disord. 2009, 27(1):59-68.
15. Griffin W.S., Sheng J.G., Royston M.C., Gentleman S.M., McKenzie J.E., Graham D.I., Roberts G.W., Mrak R.E. Glial-neuronal interactions in Alzheimer's disease: the potential role of a 'cytokine cycle' in disease progression. Brain pathology 1998, 8:65-72. (Zurich, Switzerland).
16. Grimaldi L.M., Casadei V.M., Ferri C., Veglia F., Licastro F., Annoni G., Biunno I., De Bellis G., Sorbi S., Mariani C., Canal N., Griffin W.S., Franceschi M. Association of early-onset Alzheimer's disease with an interleukin-1alpha gene polymorphism. Ann. Neurol. 2000, 47(3):361-365.
17. Harrison P., Pointon J.J., Chapman K., Roddam A., Wordsworth B.P. Interleukin-1 promoter region polymorphism role in rheumatoid arthritis: a meta-analysis of IL-1B-511A/G variant reveals association with rheumatoid arthritis. Rheumatology 2008, 47:1768-1770. (Oxford, England).
18. Hedley R., Hallmayer J., Groth D.M., Brooks W.S., Gandy S.E., Martins R.N. Association of interleukin-1 polymorphisms with Alzheimer's disease in Australia. Ann. Neurol. 2002, 51:795-797.
19. Hollingworth P., Harold D., Sims R., Gerrish A., Lambert J.C., Carrasquillo M.M., Abraham R., Hamshere M.L., Pahwa J.S., Moskvina V., Dowzell K., Jones N., Stretton A., Thomas C., Richards A., Ivanov D., Widdowson C., Chapman J., Lovestone S., Powell J., Proitsi P., Lupton M.K., Brayne C., Rubinsztein D.C., Gill M., Lawlor B., Lynch A., Brown K.S., Passmore P.A., Craig D., McGuinness B., Todd S., Holmes C., Mann D., Smith A.D., Beaumont H., Warden D., Wilcock G., Love S., Kehoe P.G., Hooper N.M., Vardy E.R., Hardy J., Mead S., Fox N.C., Rossor M., Collinge J., Maier W., Jessen F., Rüther E., Schürmann B., Heun R., Kölsch H., van den Bussche H., Heuser I., Kornhuber J., Wiltfang J., Dichgans M., Frölich L., Hampel H., Gallacher J., Hüll M., Rujescu D., Giegling I., Goate A.M., Kauwe J.S., Cruchaga C., Nowotny P., Morris J.C., Mayo K., Sleegers K., Bettens K., Engelborghs S., De Deyn P.P., Van Broeckhoven C., Livingston G., Bass N.J., Gurling H., McQuillin A., Gwilliam R., Deloukas P., Al-Chalabi A., Shaw C.E., Tsolaki M., Singleton A.B., Guerreiro R., Mühleisen T.W., Nöthen M.M., Moebus S., Jöckel K.H., Klopp N., Wichmann H.E., Pankratz V.S., Sando S.B., Aasly J.O., Barcikowska M., Wszolek Z.K., Dickson D.W., Graff-Radford N.R., Petersen R.C., van Duijn C.M., Breteler M.M., Ikram M.A., DeStefano A.L., Fitzpatrick A.L., Lopez O., Launer L.J., Seshadri S., Berr C., Campion D., Epelbaum J., Dartigues J.F., Tzourio C., Alpérovitch A., Lathrop M., Feulner T.M., Friedrich P., Riehle C., Krawczak M., Schreiber S., Mayhaus M., Nicolhaus S., Wagenpfeil S., Steinberg S., Stefansson H., Stefansson K., Snaedal J., Björnsson S., Jonsson P.V., Chouraki V., Genier-Boley B., Hiltunen M., Soininen H., Combarros O., Zelenika D., Delepine M., Bullido M.J., Pasquier F., Mateo I., Frank-Garcia A., Porcellini E., Hanon O., Coto E., lvarez V., Bosco P., Siciliano G., Mancuso M., Panza F., Solfrizzi V., Nacmias B., Sorbi S., Bossú P., Piccardi P., Arosio B., Annoni G., Seripa D., Pilotto A., Scarpini E., Galimberti D., Brice A., Hannequin D., Licastro F., Jones L., Holmans P.A., Jonsson T., Riemenschneider M., Morgan K., Younkin S.G., Owen M.J., O'Donovan M., Amouyel P., Williams J. Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat. Genet. 2011, 43(5):429-435. Alzheimer's Disease Neuroimaging Initiative, CHARGE consortiumCHARGE consortium, EADI1 consortiumEADI1 consortium.
20. Hulkkonen J., Laippala P., Hurme M. A rare allele combination of the interleukin-1 gene complex is associated with high interleukin-1 beta plasma levels in healthy individuals. Eur. Cytokine Netw. 2000, 11(2):251-255.
21. Joy S., Fein D., Kaplan E., Freedman M. Speed and memory in WAIS-R-NI digit symbol performance among healthy older adults. J. Int. Neuropsychol. Soc. 2000, 6:770-780.
22. Klimkowicz-Mrowiec A., Marona M., Wołkow P., Maruszak A., Styczynska M., Barcikowska M., Zekanowski C., Szczudlik A., Slowik A. Interleukin-1 gene -511 CT polymorphism and the risk of Alzheimer's disease in a Polish population. Dement. Geriatr. Cogn. Disord. 2009, 28(5):461-464.
23. Knopman D.S., Mosley T.H., Catellier D.J., Coker L.H. Fourteen-year longitudinal study of vascular risk factors, APOE genotype, and cognition: the ARIC MRI study. Alzheimers Dement. 2009, 5:207-214.
24. Kronfol Z. Cytokines and Mental Health 2003, Kluwer Academic Publishers, Boston.
25. Kuller L.H., Shemanski L., Manolio T., Haan M., Fried L., Bryan N., Burke G.L., Tracy R., Bhadelia R. Relationship between ApoE, MRI findings, and cognitive function in the Cardiovascular Health Study. Stroke. j. cerebral circulation 1998, 29:388-398.
26. Lee K.A., Ki C.S., Kim H.J., Sohn K.M., Kim J.W., Kang W.K., Rhee J.C., Song S.Y., Sohn T.S. Novel interleukin 1beta polymorphism increased the risk of gastric cancer in a Korean population. J. Gastroenterol. 2004, 39:429-433.
27. Licastro F., Chiappelli M. Brain immune responses cognitive decline and dementia: relationship with phenotype expression and genetic background. Mech. ageing dev. 2003, 124:539-548.
28. Licastro F., Pedrini S., Ferri C., Casadei V., Govoni M., Pession A., Sciacca F.L., Veglia F., Annoni G., Bonafe M., Olivieri F., Franceschi C., Grimaldi L.M. Gene polymorphism affecting alpha1-antichymotrypsin and interleukin-1 plasma levels increases Alzheimer's disease risk. Ann. Neurol. 2000, 48:388-391.
29. Licinio J., Wong M.L. Pathways and mechanisms for cytokine signaling of the central nervous system. J. Clin. Invest. 1997, 100:2941-2947.
30. Lopez O.L., Becker J.T., Kaufer D.I., Hamilton R.L., Sweet R.A., Klunk W., DeKosky S.T. Research evaluation and prospective diagnosis of dementia with Lewy bodies. Arch. Neurol. 2002, 59:43-46.
31. Lyketsos C.G., Lopez O., Jones B., Fitzpatrick A.L., Breitner J., DeKosky S. Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study. Jama 2002, 288:1475-1483.
32. McDowell T.L., Symons J.A., Ploski R., Forre O., Duff G.W. A genetic association between juvenile rheumatoid arthritis and a novel interleukin-1 alpha polymorphism. Arthritis and Rheumatism 1995, 38:221-228.
33. McGeer P.L., McGeer E.G. Inflammation and the degenerative diseases of aging. Ann. N. Y. Acad. Sci. 2004, 1035:104-116.
34. Morley J.E. The top 10 hot topics in aging. j. gerontology 2004, 59:24-33.
35. Naj A.C., Jun G., Beecham G.W., Wang L.S., Vardarajan B.N., Buros J., Gallins P.J., Buxbaum J.D., Jarvik G.P., Crane P.K., Larson E.B., Bird T.D., Boeve B.F., Graff-Radford N.R., De Jager P.L., Evans D., Schneider J.A., Carrasquillo M.M., Ertekin-Taner N., Younkin S.G., Cruchaga C., Kauwe J.S., Nowotny P., Kramer P., Hardy J., Huentelman M.J., Myers A.J., Barmada M.M., Demirci F.Y., Baldwin C.T., Green R.C., Rogaeva E., St George-Hyslop P., Arnold S.E., Barber R., Beach T., Bigio E.H., Bowen J.D., Boxer A., Burke J.R., Cairns N.J., Carlson C.S., Carney R.M., Carroll S.L., Chui H.C., Clark D.G., Corneveaux J., Cotman C.W., Cummings J.L., DeCarli C., DeKosky S.T., Diaz-Arrastia R., Dick M., Dickson D.W., Ellis W.G., Faber K.M., Fallon K.B., Farlow M.R., Ferris S., Frosch M.P., Galasko D.R., Ganguli M., Gearing M., Geschwind D.H., Ghetti B., Gilbert J.R., Gilman S., Giordani B., Glass J.D., Growdon J.H., Hamilton R.L., Harrell L.E., Head E., Honig L.S., Hulette C.M., Hyman B.T., Jicha G.A., Jin L.W., Johnson N., Karlawish J., Karydas A., Kaye J.A., Kim R., Koo E.H., Kowall N.W., Lah J.J., Levey A.I., Lieberman A.P., Lopez O.L., Mack W.J., Marson D.C., Martiniuk F., Mash D.C., Masliah E., McCormick W.C., McCurry S.M., McDavid A.N., McKee A.C., Mesulam M., Miller B.L., Miller C.A., Miller J.W., Parisi J.E., Perl D.P., Peskind E., Petersen R.C., Poon W.W., Quinn J.F., Rajbhandary R.A., Raskind M., Reisberg B., Ringman J.M., Roberson E.D., Rosenberg R.N., Sano M., Schneider L.S., Seeley W., Shelanski M.L., Slifer M.A., Smith C.D., Sonnen J.A., Spina S., Stern R.A., Tanzi R.E., Trojanowski J.Q., Troncoso J.C., Van Deerlin V.M., Vinters H.V., Vonsattel J.P., Weintraub S., Welsh-Bohmer K.A., Williamson J., Woltjer R.L., Cantwell L.B., Dombroski B.A., Beekly D., Lunetta K.L., Martin E.R., Kamboh M.I., Saykin A.J., Reiman E.M., Bennett D.A., Morris J.C., Montine T.J., Goate A.M., Blacker D., Tsuang D.W., Hakonarson H., Kukull W.A., Foroud T.M., Haines J.L., Mayeux R., Pericak-Vance M.A., Farrer L.A., Schellenberg G.D. Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat. Genet. 2011, 43(5):436-441.
36. Nicoll J.A., Mrak R.E., Graham D.I., Stewart J., Wilcock G., MacGowan S., Esiri M.M., Murray L.S., Dewar D., Love S., Moss T., Griffin W.S. Association of interleukin-1 gene polymorphisms with Alzheimer's disease. Ann. Neurol. 2000, 47(3):365-368.
37. Pociot F., Molvig J., Wogensen L., Worsaae H., Nerup J. A TaqI polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro. Eur. J. Clin. Investig. 1992, 22:396-402.
38. Rachal Pugh C., Fleshner M., Watkins L.R., Maier S.F., Rudy J.W. The immune system and memory consolidation: a role for the cytokine IL-1beta. Neurosci. Biobehav. Rev. 2001, 25:29-41.
39. Romero J.R., Beiser A., Seshadri S., Benjamin E.J., Polak J.F., Vasan R.S., Au R., DeCarli C., Wolf P.A. Carotid artery atherosclerosis, MRI indices of brain ischemia, aging, and cognitive impairment: the Framingham study. Stroke. j. cerebral circulation 2009, 40:1590-1596.
40. Ross F.M., Allan S.M., Rothwell N.J., Verkhratsky A. A dual role for interleukin-1 in LTP in mouse hippocampal slices. J. Neuroimmunol. 2003, 144:61-67.
41. Rothwell N.J. Annual review prize lecture cytokines - killers in the brain?. J. Physiol. 1999, 514(Pt 1):3-17.
42. Rozzini R., Ferrucci L., Losonczy K., Havlik R.J., Guralnik J.M. Protective effect of chronic NSAID use on cognitive decline in older persons. J. Am. Geriatr. Soc. 1996, 44:1025-1029.
43. Salthouse T.A. The role of memory in the age decline in digit-symbol substitution performance. J. Gerontol. 1978, 33:232-238.
44. Stern Y. The concept of cognitive reserve: a catalyst for research. Journal of clinical and experimental neuropsycholog. 2003, 25:589-593.
45. Szekely C.A., Thorne J.E., Zandi P.P., Ek M., Messias E., Breitner J.C., Goodman S.N. Nonsteroidal anti-inflammatory drugs for the prevention of Alzheimer's disease: a systematic review. Neuroepidemiology 2004, 23:159-169.
46. Teng E.L., Chui H.C. The Modified Mini-Mental State (3MS) examination. J. clin. psychiatry 1987, 48:314-318.
47. Thomas A.J., Davis S., Morris C., Jackson E., Harrison R., O'Brien J.T. Increase in interleukin-1beta in late-life depression. Am. J. Psychiatry 2005, 162:175-177.
48. Trompet S., de Craen A.J., Slagboom P., Shepherd J., Blauw G.J., Murphy M.B., Bollen E.L., Buckley B.M., Ford I., Gaw A., Macfarlane P.W., Packard C.J., Stott D.J., Jukema J.W., Westendorp R.G. Genetic variation in the interleukin-1 beta-converting enzyme associates with cognitive function. The PROSPER study. Brain 2008, 131:1069-1077.
49. Veyrieras J.B., Kudaravalli S., Kim S.Y., Dermitzakis E.T., Gilad Y., Stephens M., Pritchard J.K. High-resolution mapping of expression-QTLs yields insight into human gene regulation. PLoS Genet. 2008, 4:e1000214.
50. Vitkovic L., Bockaert J., Jacque C. "Inflammatory" cytokines: neuromodulators in normal brain?. J. Neurochem. 2000, 74:457-471.
51. Weaver J.D., Huang M.H., Albert M., Harris T., Rowe J.W., Seeman T.E. Interleukin-6 and risk of cognitive decline: MacArthur studies of successful aging. Neurology 2002, 59:371-378.
52. Wehr H., Bednarska-Makaruk M., Lojkowska W., Graban A., Hoffman-Zacharska D., Kuczynska-Zardzewialy A., Mrugala J., Rodo M., Bochynska A., Sulek A., Ryglewicz D. Differences in risk factors for dementia with neurodegenerative traits and for vascular dementia. Dement. Geriatr. Cogn. Disord. 2006, 22:1-7.
53. Whalley L.J., Deary I.J., Appleton C.L., Starr J.M. Cognitive reserve and the neurobiology of cognitive aging. Ageing research reviews. 2004, 3:369-382.
54. Wilson C.J., Finch C.E., Cohen H.J. Cytokines and cognition-the case for a head-to-toe inflammatory paradigm. J. Am. Geriatr. Soc. 2002, 50:2041-2056.
55. Yaffe K., Haan M., Byers A., Tangen C., Kuller L. Estrogen use, APOE, and cognitive decline: evidence of gene-environment interaction. Neurology 2000, 54:1949-1954.
56. Yaffe K., Lindquist K., Penninx B.W., Simonsick E.M., Pahor M., Kritchevsky S., Launer L., Kuller L., Rubin S., Harris T. Inflammatory markers and cognition in well-functioning African-American and white elders. Neurology 2003, 61:76-80.
57. Zandi P.P., Breitner J.C. Do NSAIDs prevent Alzheimer's disease? And, if so, why? The epidemiological evidence. Neurobiol. aging 2001, 22:811-817.
58. Zheng C., Huang D.R., Bergenbrant S., Sundblad A., Osterborg A., Bjorkholm M., Holm G., Yi Q. Interleukin 6, tumour necrosis factor alpha, interleukin 1beta and interleukin 1 receptor antagonist promoter or coding gene polymorphisms in multiple myeloma. Br. J. Haematol. 2000, 109:39-45.